Clinical Trial

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2025 (before its estimated December 17, 2025 completion). Its status may not reflect the trial's current state.
Summary
This trial is conducted in China. The aim of the trial is to investigate safety and efficacy of ZSP1273 granules
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-13; most recent amendment 2025-12-08.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-12-08
Trial Details
NCT Number NCT07229807
Lead Sponsor Guangdong Raynovent Biotech Co., Ltd
Conditions Influenza a
Enrollment 119 participants
Start Date 2025-11-22
Primary Completion 2025-12-17 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16